US Edition
Published • loading... • Updated
As demand for GLP-1 pills and shots surges, healthy habits are still key
About 1 in 8 U.S. adults use GLP-1 drugs for weight loss and health, but experts emphasize that lifestyle changes are essential for lasting results.
- U.S. adults are increasingly using GLP-1 drugs, with about 1 in 8 reporting use and over 600,000 prescriptions for Wegovy since January, experts say.
- Experts note the drugs work biologically by targeting gut and brain hormones to slow digestion and curb appetite, while clinical trial programs included structured lifestyle components and Truveta shows over a third of users are new.
- A review of nearly three dozen studies shows GLP-1 effects last longer when combined with lifestyle changes, and a February veterans study found a 43% lower cardiovascular risk with six to eight healthy habits.
- Obesity specialists warn the biggest mistake is thinking the prescription is the whole treatment, while Dr. Jody Dushay urges monitoring health markers and Dr. Katherine Saunders notes rare side effects require close follow-up.
- Beyond individual benefit, GLP-1s may change public-health approaches because they produce significant weight loss and improved health markers, but social media and advertising create a quick-fix impression, Dr. Katherine Saunders said.
Insights by Ground AI
24 Articles
24 Articles
Associated Press News+22 Reposted by 22 other sources
As demand for GLP-1 pills and shots surges, healthy habits are still key
Use of blockbuster anti-obesity drugs like Wegovy and Zepbound is growing, with about 1 in 8 adults in the U.S. saying they currently take the medications.
·United States
Read Full Article
As demand for GLP-1 pills and shots surges, healthy habits are still key - Regional Media News
Whether they're using weekly shots or daily pills, more Americans than ever are turning to anti-obesity drugs to lose weight and boost health. About 1 in 8 U.S. adults say they are taking a GLP-1 drug, according to a recent survey by the health research group KFF. Just since January, more than 600,000 prescriptions have been written for Novo Nordisk's new Wegovy pill, the company said. Early analysis suggests that more than a third of users are …
Coverage Details
Total News Sources24
Leaning Left9Leaning Right2Center12Last UpdatedBias Distribution52% Center
Bias Distribution
- 52% of the sources are Center
52% Center
L 39%
C 52%
Factuality
To view factuality data please Upgrade to Premium
